industry > industry > Pharmaceuticals Pharmaceuticals GlaxoSmithKline, Daiichi in hypertension drug deal in India 14 May 2008 Intercell to acquire Iomai Corporation for $189 million 13 May 2008 Ranbaxy to develop new drugs for Merck & Co 10 May 2008 Johnson & Johnson patent lawsuit agains Boston Scientific's NIR stent dismissed in Canada 09 May 2008 Jubilant Organosys acquires Speciality Molecules for about Rs20 crore 08 May 2008 Enzon Pharma to spin off biotechnology business 08 May 2008 Novo Nordisk researchers nominated for Europe’s top innovation prize for new version of insulin 06 May 2008 GSK Pharma signs licensing agreement with Astellas of Japan 05 May 2008 Indian vultures face extinction due to diclofenac poisoning 05 May 2008 Divested from Esperion Therapeutics completes $22.75-million series A financing 03 May 2008 Bristol-Myers Squibb sells ConvaTec to PE firms for $4.1 billion 03 May 2008 Merck extends enrollment deadline for US Vioxx product liability lawsuit claimants 03 May 2008 Teams unravel heparin death mystery 02 May 2008 Dr Reddy's acquires BASF's contract manufacturing business in US 30 April 2008 Novartis Research announces breakthrough in restoring light sensitivity in damaged retinas 29 April 2008 US FDA turns down Merck's ER niacin / laropiprant 29 April 2008 Ranbaxy gets a boost as US patent office rejects Pfizer's Liptor plea 28 April 2008 Brazil declares anti-AIDS drug to be of public interest; India's pharma industry may benefit 28 April 2008 Pfizer forms diabetes, obesity research consortium with universities 26 April 2008 Government brings 1,421 drugs under Price Control Order 25 April 2008 GlaxoSmithKline acquires Sirtris Pharmaceuticals 24 April 2008 Delhi HC upholds ruling in Cipla-Roche cancer drug row 23 April 2008 Ranbaxy forces Orchid into an alliance 22 April 2008 Dabur Pharma to sell majority stake to Singapore-based Fresenius Kabi Pte Ltd 19 April 2008 Nicholas Piramal buys two Khandelwal Laboratories brands for Rs116 crore 16 April 2008 Ranbaxy settles litigation with AstraZeneca; to sell Nexium in US 15 April 2008 Why Ranbaxy fancies Orchid 14 April 2008 Ranbaxy group closer to 15 per cent stake in Orchid 14 April 2008 Ranbaxy's Solrex picks up 1 per cent more in Orchid Chemicals 11 April 2008 Japan's Takeda to acquire Millennium Pharma for $8.8 billion 10 April 2008 Glenmark's Swiss arm completes Phase I trials for monoclonal antibody GBR 500 10 April 2008 Orchid Chemicals announces Japanese subsidiary 10 April 2008 Orchid Chemicals stock surges as Ranbaxy group hikes stake 08 April 2008 Ranbaxy receives Japanese authorisation for product development outside Japan 08 April 2008 Dr Reddy's acquires Jet Generici Srl; to establish generics range in Italy 03 April 2008 Ranbaxy introduces world's first biogeneric injectible drug for osteoporosis 03 April 2008 Teva to acquire Bentley Pharmaceuticals 01 April 2008 Dr Reddy's to buy two Dowpharma Small Molecules units in the UK 01 April 2008 Indian Pharma Industry should make 40 per cent of the world's generic drugs: APJ Abdul Kalam 31 March 2008 Aurobindo acquires Italian generic pharma firm TAD 24 March 2008 Wockhardt says derivative losses not to affect Q1 performance 24 March 2008 Cipla to continue selling its version of Roche's lung cancer treatment drug 20 March 2008 Japan's biggest drug maker to expand in the US 20 March 2008 Sun Pharma gets US FDA approval to market generic Cerebyx 20 March 2008 Ranbaxy to introduce dental drug Inersan in India, Nepal 18 March 2008 USFDA approves Sun Pharmaceutical's generic cancer drug Ethyol in US markets 17 March 2008 Glenmark Pharmaceuticals launches Clobetasol from its niche dermatology pipeline 17 March 2008 SC refuses to stay Gujarat HC order on Ranbaxy's 'Volini' ad 12 March 2008 Suven Life signs another drug research pact with Eli Lilly 12 March 2008 Dr Reddy's Laboratories and 7TM Pharma sign drug research pact 10 March 2008 USFDA grants tentative approval to Sun Pharma's generic anti-cancer injection Gemzar 07 March 2008 Pfizer to acquire Serenex, extend oncology pipeline 05 March 2008 Drug Controller approves Venus Remedies' latest antibiotic drug 04 March 2008 Drugs to become cheaper: Ram Vilas Paswan 01 March 2008 Dabur launches injection for cancer treatment in US 29 February 2008 Baxter withdraws heparin blood thinners made from Chinese supplies 29 February 2008 Matrix Labs may divest Docpharma 28 February 2008 Shasun Chemicals technology licenses API technology to Merck 27 February 2008 New Novartis Research Institute first to focus on innovative vaccines for the developing world 23 February 2008 Nicholas Piramal Research in India's first public-private drug research project 22 February 2008 Sun Pharmaceutical buys Taro Pharma shares from Brandes 20 February 2008 Ranbaxy board approves de-merger of new drug discovery research unit in to Ranbaxy Life Science Research Ltd 19 February 2008 AstraZeneca forms clinical research venture with private equity firms 18 February 2008 Zydus Cadila launches new drug for cancer therapy 15 February 2008 Nicholas Piramal R&D arm in $110-million new drug deal with Eli Lilly 15 February 2008 Patent expiries destabilise global pharmaceutical majors, says Datamonitor research 14 February 2008 Wockhardt's Azithromycin to battle Pfizer's Zithromax in the US market 13 February 2008 Bayer HealthCare affiliate MEDRAD to acquire devises maker Possis Medical 12 February 2008 Strides Arcolab acquires 17.7-per cent stake in Genepharm Australasia 08 February 2008 Alpharma divests API business to 3i for $395 million 07 February 2008 Nicholas Piramal launches hypertension product 07 February 2008 USFDA grants tentative approval to Ranbaxy's esomeprazole magnesium DR capsules in the US 07 February 2008 Glenmark receives milestone payment from Forest Labs for phase II study on Oglemilat 06 February 2008 US FDA approves Ranbaxy's generic version of GlaxoSmithKline's Ceftin for US sales 06 February 2008 DiaGenic announces preliminary results from Indian breast cancer study 05 February 2008 Amgen and Takeda announce exclusive collaboration in Japan on up to 13 Amgen clinical candidates 04 February 2008 US FDA grants tentative approval to Teva's generic Flomax capsules 01 February 2008 Sun Pharma launches generic version of Wyeth's Protonix 30 January 2008 Shasun Chemicals to set up new facilities in N. America 28 January 2008 US FDA approves Glenmark Pharmaceuticals Baddi semi-solids plant 28 January 2008 Matrix Laboratories hikes stake in China's Mchem to 97 per cent 25 January 2008 Novo Nordisk divests three metabolic-disorder treatment programmes to TransTech Pharma 25 January 2008 Anti-smoking vaccines set to help millions; to boost prescription market 25 January 2008 Zydus Cadila to collaborate with US-based Prolong Pharmaceuticals for drug discovery 24 January 2008 Roche to acquire Ventana for $89.50 per share 23 January 2008 Teva to acquire CoGenesys 23 January 2008 Nicholas Piramal buys Healthline's pharmaceuticals business 23 January 2008 Suven Life Sciences receives second US patent 23 January 2008 Ranbaxy announces settlement of possible Imitrex litigation with Glaxosmithkline 21 January 2008 Dr Reddy's announces settlement of Exelon (rivastigmine tartrate ) ANDA litigation with Novartis 21 January 2008 Wockhardt to demerge R&D business 18 January 2008 Pfizer-funded study reports reduction in heart attacks by adding Lipitor early to blood pressure treatment 18 January 2008 India asks Indonesia to remove non-tariff barriers on Indian pharma products 18 January 2008 WHO grants international non-proprietary name Melogliptin to Glenmark Pharmaceuticals's anti-diabetic drug 14 January 2008 Ranbaxy enters Chyawanprash market with suger-free `Chyawan Active' 11 January 2008 US wants to open FDA office in India 11 January 2008 Strides Arcolab discontinues manufacturing operations in New Jersey 09 January 2008 Genzyme and Isis announce strategic alliance including exclusive worldwide license of Mipomersen 08 January 2008 Marksans Pharma acquires UK’s Hale Group Ltd, owner of Bell, Sons & Co 07 January 2008 Panacea Biotec pre-qualified by WHO to supply children's immunisation drug 05 January 2008 National Pharmaceutical Pricing Authority seeks cost data from pharmaceutical industry 04 January 2008 Cephalon seeks second use for chemo drug 03 January 2008 Wockhardt enters billion-dollar anti-allergic Zyrtec market in the US 02 January 2008 Suven Life Sciences receives first product patent in the US 27 December 2007 Aurobindo Pharma gets US approval to sell generic Omnicef 19 December 2007 Nicholas Piramal in JV with Japan's Arkray to market blood glucose monitoring products 19 December 2007 Health minister to release Indian Pharmacopoeia 2007 17 December 2007 Novartis plans to cut 22,00 jobs worldwide 13 December 2007 Drug prices fixed under DPCO 1995 have to be compulsorily implemented: Government 11 December 2007 Nicholas Piramal's cyclin-dependent kinase inhibitors granted US product patent 11 December 2007 Eli Lilly predicts higher 2008 profit; to launch new products by 2011 07 December 2007 Bristol-Myers Squibb will cut jobs, close plants, to save $1.5 billion 07 December 2007 US FDA panel rejects the use of Genentech’s Avastin for breast cancer 07 December 2007 Sun Pharma announces settlement of litigation over generic Exelon 06 December 2007 Matrix Labs gets US FDA nod for HIV drug 05 December 2007 Abbott Labs cuts 1,200 jobs as drug-coated heart stent market shrinks 05 December 2007 French drug giant Sanofi-Aventis opens R&D centre in Goa 05 December 2007 Pfizer to outsource 30 per cent of manufacturing to Asia, cut 10,000 jobs 04 December 2007 Bristol-Myers Squibb likely to cut 4,300 jobs 01 December 2007 Astellas acquiring cancer biotech firm Agensys 27 November 2007 Aurobindo Pharma receives five product approvals from USFDA including two Paragraph IV products 24 November 2007 Nicholas Piramal in R&D collaboration with Merck & Co 19 November 2007 Pfizer to acquire Coley Pharmaceutical for $164 million 19 November 2007 US FDA approval Orchid's ANDA for Cefpodoxime Proxetil 17 November 2007 Dr Reddy's gets US FDA nod for marketing Ciprofloxacin 17 November 2007 Glenmark Pharma to spin off generics unit, list new unit next year 17 November 2007 Merck agrees to settle Vioxx claims for $4.85 billion 15 November 2007 GSK to launch cancer drug Tykerb in India 10 November 2007 Contract research firm Manipal AcuNova acquires Germany''s ECRON 05 November 2007 Pfizer to license Taisho Pharmaceutical''s schizophrenia drug candidate TS-032 01 November 2007 Biocon plans Rs 100 crore annual research spend 31 October 2007 Ranbaxy wins patent case against Pfizer cholestrol drug Liptor in Germany 30 October 2007 US state Utah seeks co-operation with India in life science research 30 October 2007 Glenmark signs up marketing deal with MyerZall Labs 27 October 2007 Sigma-Aldrich, Oxford BioMedica win key ruling in Open Biosystems patent infringement dispute 26 October 2007 Glenmark and MeyerZall Laboratories to offers topical dermatology products in South Africa 25 October 2007 Ranbaxy launches Osonase nasal spray in India 25 October 2007 Suven Life Sciences, University of Minnesota to develop drugs jointly to treat HIV 25 October 2007 US FDA approves Sun Pharmaceutical''s Novartis-equivalent generic Exelon capsules for US markets 24 October 2007 Wockhardt acquires US pharma firm Morton Grove Pharmaceuticals 24 October 2007 Dabur enters supply and distribution agreement with Combino Pharm 24 October 2007 Researchers see role for `septins'' in treatment of Alzheimer''s, Parkinson''s 20 October 2007 Himalaya Drug Company to expand retail presence 19 October 2007 Medical Retail chain Medicine Shoppe to expand network outside Mumbai 19 October 2007 Ranbaxy follows Sun Pharma in demerging R&D business 19 October 2007 USV in marketing tie-up with Germany''s Sebapharma 19 October 2007 Drug Controller-General approves Biocon - Abraxis BioScience breast cancer drug Abraxane 19 October 2007 Ranbaxy plans to spin off research arm as Q3 net profit zooms 48 per cent 18 October 2007 Panjab University and Panacea Biotec to develop new chemical entities 10 October 2007 Government plans central authority for drug licensing 08 October 2007 Avesthagen-Cipla JV acquires Siegfried Biologics in Germany 05 October 2007 Accenture and Bristol-Myers Squibb launch pharmaceutical industry''s first joint centre for pharmacovigilance 14 September 2007 Toray develops Hepatitis C vaccine 28 August 2007 Matrix to acquire residual holding in China''s Mchem group 25 August 2007 No data on of siphoning of funds by pharmaceutical companies: Minister 24 August 2007 Roche secures US court injunction for its Ventana bid 23 August 2007 Boston Scientific to explores divestment of surgical products unit 18 August 2007 Ranbaxy could gain as Pfizer loses initial bid for Lipitor patent extension 17 August 2007 Ajanta Pharma out licences formulation technology to Taiwan''s Orient Europharma 16 August 2007 Ipca-Ranbaxy alliance to market Metformin HCL tablets in US 14 August 2007 Lupin to invest Rs200 crore in new plant, capacity addition 10 August 2007 Unigene Laboratories acquires exclusive licence for therapies from University of London 10 August 2007 Biocon in pact with Abraxis to market breast cancer drug Abraxane in India 09 August 2007 Switzerland not to take Novartis case before WTO 08 August 2007 Patent tussle fallout: MNCs may turn cautious on India 07 August 2007 Bayer HealthCare and Nektar Therapeutics to develop innovative therapy for pneumonia 06 August 2007 Strides Arcolab completes acquisition of Diaspa''s fermentation facility in Italy 06 August 2007 Chennai court rejects Novartis patent challenge 06 August 2007 KKR Boots' debt may devolve on underwriters 04 August 2007 Dr Reddy's and Rheoscience commence Phase III diabetes drug trials 02 August 2007 Genstar makes another grab for PRA 31 July 2007 Merck buys cardiac biotech start-up NovaCardia 31 July 2007 Indonesia bans cosmetics, medicine and food from China 30 July 2007 Biocon enters into JV with Neopharma of UAE 30 July 2007 Ranbaxy to sell authorised generics product Isoptin SR in US 30 July 2007 Genstar to acquire contract drug manufacturer PRA for second time 28 July 2007 SNC-Lavalin acquires pharma engineering firm Pipecon 27 July 2007 Merck to acquire NovaCardia for $350 million 27 July 2007 Aventis group firm acquires diabetes drug technology from Themis 26 July 2007 Ranbaxy, GSK to settle valacyclovir patent case in US 26 July 2007 Elder Pharma to acquire 20 per cent stake in UK's Neutra Health 26 July 2007 GlaxoSmithKline pharmaceuticals divests fine 26 July 2007 Neutra Health acquisition to facilitate entry into regulated markets: Elder Pharma 26 July 2007 Significant opportunities for Ranbaxy from GlaxoSmithKline deal: Malvinder Singh 26 July 2007 Teleflex avquires medical products maker Arrow for $2 billion 25 July 2007 Nicholas Piramal''s new drug IND-P276 approved by US FDA 25 July 2007 Swedish pharma firm Meda to acquire Medpointe 23 July 2007 China asks tainted food and drug firms to shut down 23 July 2007 Purdue Pharma fined $634 million for OxyContin deaths; executives punished 22 July 2007 Court revives shareholder lawsuits over Vioxx against Merck 20 July 2007 Glenmark acquires rights to two therapeutic antibodies from Chromos 19 July 2007 Lupin gets DCGI nod for phase II and III clinical trials of herbal psoriasis drug 19 July 2007 Abraxis BioScience to license biosynthetic cancer drug from Biocon 19 July 2007 Orchid Chem to launch three new products in the US 18 July 2007 World Bank blacklist two Indian pharma companies for ''collusive'' practices 17 July 2007 Rebuffed by Ventana, Roche may increase its $3-billion bid 13 July 2007 Dishman Pharma to acquire Solvay's Dutch fine chemicals unit 09 July 2007 Novartis AG receives first worldwide approval in US for Alzheimer''s patch 09 July 2007 Roche goes to court over Ventana''s poison-pill defence 05 July 2007 Roche makes hostile offer for Ventana 27 June 2007 Roche buys Toyama''s arthritis drug for $370 million 26 June 2007 Ranbaxy to benefit from 180-day US market exclusivity for its pravastatin 25 June 2007 Zydus Cadila acquires Brazilian company Nikkho 25 June 2007 US panel blocks Sanofi''s weight-loss drug 16 June 2007 China slaps anti-dumping duty on antibiotic from India 16 June 2007 Dr Reddy's commences operations in Nigeria 16 June 2007 Aurobindo Pharma rules out stake sale 13 June 2007 Rising disease may take India to top 10 pharma markets by 2020 13 June 2007 Strides Arcolab acquires Grandix for Rs100 cr 12 June 2007 Nicholas Piramal in tie-up for cancer, diabetes research 11 June 2007 Nigeria sues Pfizer for illegal drug trials, claims $7 billion in damages 05 June 2007 Strides Arcolab to buy Italian Diaspa''s drug unit 29 May 2007 Ranbaxy buys 13 dermatology brands from Bristol-Myers 28 May 2007 Alembic enters into licensing pact with Belgian co 24 May 2007 Indian pharma to grow big in few years 24 May 2007 NPPA strikes drug firms for raising MRP 24 May 2007 Lupin receives tentative US FDA approval for anti-psychotic drug Ziprasidone 21 May 2007 Sun Pharmaceutical to acquire Taro Pharma for $454 million 21 May 2007 Dr Reddy's is setting up two SEZs 19 May 2007 Glenmark receives US FDA approval for cardiac and NSAIDs generics 16 May 2007 Mylan Laboratories to acquire Merck generics unit for $6.6 billion 14 May 2007 FDA fines US drug firm $634m over painkiller misleads 11 May 2007 FDA panel seeks curbs on Amgen, J&J anaemia drugs 11 May 2007 Dabur Pharma sets up US subsidiary 09 May 2007 Wockhardt acquires France`s Negma Labs for Rs1,090 crore 03 May 2007 Internal accruals to fund Negma acquisition: Khorakiwala 03 May 2007 AstraZeneca to acquire US biotech firm MedImmune for $15.6 billion 28 April 2007 Jubilant Organosys acquires Hollister-Stier of US for $122.5 million 26 April 2007 KKR-Pessina combine to buy Alliance Boots for $22.2 billion 25 April 2007 US FDA approves Ranbaxy''s pravastatin sodium tablets 25 April 2007 Wockhardt to launch Italy''s B-Lift range of dermatology products in India 23 April 2007 Zydus Cadila acquires Nippon Universal of Japan 19 April 2007 19 April 2007 Wockhardt to introduce treatment for dermatological scars 17 April 2007 Nestle to acquire Gerber for $5.5 billion; eyes US expansion 12 April 2007 Lupin gets USFDA approval for paediatric Suprax oral suspension 12 April 2007 Bidding battle expected for Boots 10 April 2007 Government warns Novartis of compulsory licensing 10 April 2007 Orchid enters Canadian market with two generic formulations 10 April 2007 Lupin sells part rights of 'perindopril' to French firm for Rs115 crore 07 April 2007 Ranbaxy Labs acquires 14.9-per cent stake in Jupiter Bio Science 07 April 2007 India court reserves order in Novartis patent case 05 April 2007 Terapia Ranbaxy receives 3-year GMP certification renewal for Bucharest facility 04 April 2007 Ranbaxy-GSK alliance to develop respiratory drug 02 April 2007 Eli Lilly sues Sun Pharma over patent for cancer drug 02 April 2007 Alliance Boots gets revised $20 billion offer from KKR, Pessina 31 March 2007 Novartis slumps after pulling Zelnorm 31 March 2007 Ranbaxy launches asthma drug 'Osovair' in India 30 March 2007 Strides Arcolab gets tentative US FDA nod for AIDS drug 29 March 2007 Glenmark confirms filing ANDA with ''paragraph IV certification'' for Zetia tablets 28 March 2007 Wockhardt receives US FDA approval for diuretic injection 28 March 2007 Government to enforce 5-per cent cut in prices of 75 drugs 27 March 2007 Glenmark acquires Czech firm Medicamanta 26 March 2007 Is Torrent a serious contender for Merck? 23 March 2007 Opportunities for India in generic drug space 21 March 2007 Ranbaxy withdraws bid for Merck's generic business 20 March 2007 Zydus Cadila acquires Liva Healthcare 17 March 2007 Ranbaxy enters second round of bidding for Merck unit: report 16 March 2007 Ranbaxy gets USFDA nod for zolpidem tablet production in US 16 March 2007 Strides Arcolab receives US FDA approvals for two new drugs 14 March 2007 Biocon arm to set up dedicated R&D facility for Bristol-Myers Squibb 14 March 2007 Akzo Nobel sells Organon BioSciences to Schering-Plough for €11 billion 13 March 2007 Ranbaxy Laboratories Bids for Merck''s Generic Unit 13 March 2007 Boots rejects KKR's £9.7 billion offer as being low 13 March 2007 Lupin gets marketing approval for cefpodoxime proxetil in France 13 March 2007 Merck suffers adverse Vioxx lawsuit in the US 13 March 2007 Boots to consider KKR's £9.7 billion offer 12 March 2007 Glenmark in funded research agreement with Swiss firm Dyax 12 March 2007 After acquiring Schering, Bayer to cut 6,100 jobs worldwide 03 March 2007 US firm acquires global rights for anti-cholestrol drug from Ranbaxy 01 March 2007 Ranbaxy plans ADS offering to finance Merck arm acquisition 21 February 2007 Biocon to invest Rs 1,000 crore in Vizag SEZ 17 February 2007 ADAG to rewrite drug distribution rules 10 February 2007 Ranbaxy enters biosimilar product space with Zenotech, targets EU markets 08 February 2007 Ranbaxy-Glaxo extend pact 07 February 2007 Pfizer loses battle for Chinese name for Viagra 06 February 2007 Dr Reddy's to join the race for Merck's generic business 05 February 2007 Glaxo moves court against Ranbaxy''s generic drug 03 February 2007 Wyeth sued over Zosyn patent 03 February 2007 Global collaboration to develop new anti-obesity compounds 02 February 2007 Pfizer wins Norvasc patent case against Synthon 02 February 2007 Novartis patent case a threat to developing nations: Medecins Sans Frontieres 30 January 2007 Ranbaxy launches two NDDS Urology products in India 30 January 2007 Sun Pharma to acquire companies in the US 24 January 2007